Cargando…
Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with limited therapeutic options available. We have recently demonstrated that lovastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, suppresses TNBC cell proliferation and stemness prope...
Autores principales: | Xue, Lian, Wu, Mi, Li, Ying, Chen, Sisi, Wu, Muyao, Zhu, Jianyu, Ding, Siyu, Zhang, Qiuting, Zheng, Chanjuan, He, Guangchun, Fu, Shujun, Li, Guifei, Deng, Xiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516013/ https://www.ncbi.nlm.nih.gov/pubmed/36186902 http://dx.doi.org/10.7150/jca.71592 |
Ejemplares similares
-
Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer
por: Chen, Sisi, et al.
Publicado: (2022) -
Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins
por: Zheng, Chanjuan, et al.
Publicado: (2021) -
Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells
por: Yi, Huimei, et al.
Publicado: (2020) -
Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
por: Zheng, Chanjuan, et al.
Publicado: (2023) -
Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis
por: Zhang, Qiuting, et al.
Publicado: (2021)